Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377 AVXL Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued RD Focus InspireMD Inc NSPR Q1 2026 Earnings Narrower Loss Than Expected But Shares Slide SPB Q1 2026 Earnings Strong EPS Beat Drives Share Gains Despite Missing Revenue Details WORX Q3 2025 Earnings Net Loss Deepens as Stock Declines Sharply ORGN Q4 2025 Earnings Massive EPS Miss Highlights Ongoing Business Restructuring